These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
210 related items for PubMed ID: 31634297
1. Cerebrospinal Fluid Pleocytosis and Elevated C-X-C Motif Chemokine Ligand 13 Value Predict Lyme Borreliosis in Children With Facial Palsy. Pöyhönen H, Lähdesmäki T, Hytönen J, Peltola V. Pediatr Infect Dis J; 2019 Dec; 38(12):1195-1198. PubMed ID: 31634297 [Abstract] [Full Text] [Related]
9. [Diagnostic difficulties in neuroborreliosis in children]. Talarek E, Duszczyk E, Zarnowska H. Przegl Epidemiol; 2007 Sep; 61(1):73-8. PubMed ID: 17702442 [Abstract] [Full Text] [Related]
10. Validation of a clinical prediction rule to distinguish Lyme meningitis from aseptic meningitis. Cohn KA, Thompson AD, Shah SS, Hines EM, Lyons TW, Welsh EJ, Nigrovic LE. Pediatrics; 2012 Jan; 129(1):e46-53. PubMed ID: 22184651 [Abstract] [Full Text] [Related]
11. CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis. Ljøstad U, Mygland A. J Neurol; 2008 May; 255(5):732-7. PubMed ID: 18344056 [Abstract] [Full Text] [Related]
12. [CXCL13: a biomarker for acute Lyme neuroborreliosis: investigation of the predictive value in the clinical routine]. Rupprecht TA, Lechner C, Tumani H, Fingerle V. Nervenarzt; 2014 Apr; 85(4):459-64. PubMed ID: 24682168 [Abstract] [Full Text] [Related]
13. The recomBead Borrelia antibody index, CXCL13 and total IgM index for laboratory diagnosis of Lyme neuroborreliosis in children. Skogman BH, Lager M, Henningsson AJ, Tjernberg I. Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2221-2229. PubMed ID: 28730535 [Abstract] [Full Text] [Related]
14. Acute facial nerve palsy in children: how often is it lyme borreliosis? Tveitnes D, Øymar K, Natås O. Scand J Infect Dis; 2007 Nov; 39(5):425-31. PubMed ID: 17464865 [Abstract] [Full Text] [Related]
15. Cerebrospinal fluid CXCL13 as a diagnostic marker of neuroborreliosis in children: a retrospective case-control study. Remy MM, Schöbi N, Kottanattu L, Pfister S, Duppenthaler A, Suter-Riniker F. J Neuroinflammation; 2017 Aug 31; 14(1):173. PubMed ID: 28859668 [Abstract] [Full Text] [Related]
17. CXCL13 may improve diagnosis in early neuroborreliosis with atypical laboratory findings. Borde JP, Meier S, Fingerle V, Klier C, Hübner J, Kern WV. BMC Infect Dis; 2012 Dec 10; 12():344. PubMed ID: 23228054 [Abstract] [Full Text] [Related]
18. A prospective study on the role of CXCL13 in Lyme neuroborreliosis. Schmidt C, Plate A, Angele B, Pfister HW, Wick M, Koedel U, Rupprecht TA. Neurology; 2011 Mar 22; 76(12):1051-8. PubMed ID: 21422457 [Abstract] [Full Text] [Related]
19. The chemokine CXCL13 in acute neuroborreliosis. Senel M, Rupprecht TA, Tumani H, Pfister HW, Ludolph AC, Brettschneider J. J Neurol Neurosurg Psychiatry; 2010 Aug 22; 81(8):929-33. PubMed ID: 19965843 [Abstract] [Full Text] [Related]
20. Lyme neuroborreliosis with antibodies in cerebrospinal fluid but not in serum. Zomer TP, Bruinsma R, van Samkar A, Vermeeren YM, Wieberdink RG, van Kooten B, van Bemmel T. Eur J Neurol; 2023 Mar 22; 30(3):741-744. PubMed ID: 36371644 [Abstract] [Full Text] [Related] Page: [Next] [New Search]